| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 12 | 2016 | 141 | 1.350 |
Why?
|
| Low Back Pain | 9 | 2022 | 59 | 1.180 |
Why?
|
| Chronic Pain | 9 | 2023 | 125 | 1.140 |
Why?
|
| Massage | 6 | 2015 | 16 | 1.110 |
Why?
|
| Internet | 9 | 2014 | 207 | 0.940 |
Why?
|
| Cluster Analysis | 5 | 2022 | 88 | 0.930 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 6 | 2014 | 57 | 0.870 |
Why?
|
| Humans | 72 | 2024 | 16832 | 0.860 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2023 | 317 | 0.860 |
Why?
|
| Outcome Assessment (Health Care) | 6 | 2017 | 199 | 0.780 |
Why?
|
| Breast Neoplasms | 10 | 2016 | 913 | 0.780 |
Why?
|
| Hypertension | 7 | 2014 | 475 | 0.770 |
Why?
|
| Clinical Competence | 3 | 2016 | 107 | 0.750 |
Why?
|
| Electronic Health Records | 8 | 2023 | 702 | 0.680 |
Why?
|
| Research Design | 7 | 2020 | 319 | 0.650 |
Why?
|
| Neck Pain | 3 | 2015 | 12 | 0.650 |
Why?
|
| Mindfulness | 5 | 2022 | 30 | 0.640 |
Why?
|
| Models, Statistical | 5 | 2022 | 164 | 0.640 |
Why?
|
| Propensity Score | 2 | 2019 | 78 | 0.620 |
Why?
|
| Product Surveillance, Postmarketing | 5 | 2014 | 99 | 0.620 |
Why?
|
| Rubella | 1 | 2019 | 6 | 0.590 |
Why?
|
| Mumps | 1 | 2019 | 13 | 0.580 |
Why?
|
| Chickenpox | 1 | 2019 | 35 | 0.570 |
Why?
|
| Vaccines, Combined | 1 | 2019 | 80 | 0.570 |
Why?
|
| Seizures, Febrile | 1 | 2019 | 42 | 0.570 |
Why?
|
| Measles | 1 | 2019 | 25 | 0.570 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2019 | 64 | 0.570 |
Why?
|
| Biometry | 2 | 2009 | 13 | 0.560 |
Why?
|
| Chickenpox Vaccine | 1 | 2019 | 91 | 0.560 |
Why?
|
| Antihypertensive Agents | 4 | 2014 | 157 | 0.540 |
Why?
|
| Female | 45 | 2024 | 12193 | 0.540 |
Why?
|
| Middle Aged | 35 | 2024 | 7515 | 0.520 |
Why?
|
| Early Detection of Cancer | 4 | 2022 | 553 | 0.510 |
Why?
|
| Adult | 33 | 2022 | 7255 | 0.490 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 39 | 0.470 |
Why?
|
| Gastric Bypass | 3 | 2022 | 71 | 0.460 |
Why?
|
| Male | 36 | 2024 | 9556 | 0.460 |
Why?
|
| Pharmaceutical Services | 2 | 2013 | 37 | 0.450 |
Why?
|
| Geography | 2 | 2015 | 39 | 0.440 |
Why?
|
| Treatment Outcome | 14 | 2022 | 1098 | 0.420 |
Why?
|
| Bariatric Surgery | 3 | 2022 | 134 | 0.410 |
Why?
|
| Aged | 27 | 2023 | 5901 | 0.410 |
Why?
|
| Stress, Psychological | 5 | 2022 | 136 | 0.400 |
Why?
|
| Cardiovascular Diseases | 5 | 2021 | 520 | 0.390 |
Why?
|
| Clinical Protocols | 4 | 2016 | 38 | 0.380 |
Why?
|
| Self-Assessment | 1 | 2012 | 14 | 0.370 |
Why?
|
| Residence Characteristics | 5 | 2024 | 244 | 0.360 |
Why?
|
| Gastrectomy | 3 | 2022 | 47 | 0.350 |
Why?
|
| Washington | 12 | 2019 | 376 | 0.350 |
Why?
|
| Diet | 4 | 2020 | 349 | 0.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 677 | 0.340 |
Why?
|
| Cohort Studies | 8 | 2022 | 2396 | 0.340 |
Why?
|
| Computer Simulation | 4 | 2022 | 84 | 0.330 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2012 | 104 | 0.330 |
Why?
|
| Mass Screening | 5 | 2017 | 670 | 0.330 |
Why?
|
| Primary Health Care | 4 | 2019 | 693 | 0.320 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2009 | 5 | 0.300 |
Why?
|
| Prospective Studies | 8 | 2023 | 1186 | 0.290 |
Why?
|
| Obesity, Morbid | 2 | 2022 | 122 | 0.280 |
Why?
|
| Yoga | 3 | 2016 | 25 | 0.280 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2016 | 353 | 0.280 |
Why?
|
| Telemedicine | 3 | 2023 | 190 | 0.280 |
Why?
|
| Radiology | 4 | 2012 | 7 | 0.270 |
Why?
|
| United States | 13 | 2020 | 3858 | 0.270 |
Why?
|
| Biostatistics | 3 | 2016 | 11 | 0.250 |
Why?
|
| Diagnostic Errors | 3 | 2012 | 30 | 0.250 |
Why?
|
| Quality Improvement | 3 | 2016 | 184 | 0.240 |
Why?
|
| Obesity | 6 | 2020 | 811 | 0.230 |
Why?
|
| Health Promotion | 3 | 2017 | 277 | 0.220 |
Why?
|
| Population Surveillance | 2 | 2019 | 242 | 0.220 |
Why?
|
| Socioeconomic Factors | 7 | 2019 | 571 | 0.210 |
Why?
|
| False Positive Reactions | 4 | 2012 | 25 | 0.210 |
Why?
|
| Young Adult | 13 | 2017 | 2456 | 0.200 |
Why?
|
| Data Collection | 4 | 2012 | 223 | 0.200 |
Why?
|
| Nutrition Policy | 2 | 2020 | 18 | 0.190 |
Why?
|
| Food | 3 | 2024 | 36 | 0.190 |
Why?
|
| Housing | 2 | 2015 | 38 | 0.190 |
Why?
|
| Regression Analysis | 5 | 2017 | 261 | 0.190 |
Why?
|
| Infant | 3 | 2019 | 1212 | 0.190 |
Why?
|
| Colorectal Neoplasms | 2 | 2019 | 635 | 0.180 |
Why?
|
| Surveys and Questionnaires | 9 | 2019 | 1204 | 0.180 |
Why?
|
| Herpes Zoster Vaccine | 1 | 2023 | 60 | 0.180 |
Why?
|
| Bias | 2 | 2019 | 90 | 0.180 |
Why?
|
| Postoperative Complications | 2 | 2020 | 103 | 0.180 |
Why?
|
| Computer-Assisted Instruction | 2 | 2012 | 9 | 0.180 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 186 | 0.170 |
Why?
|
| Health Status Disparities | 2 | 2015 | 145 | 0.170 |
Why?
|
| Herpes Zoster | 1 | 2023 | 80 | 0.170 |
Why?
|
| Education, Medical, Continuing | 2 | 2012 | 28 | 0.170 |
Why?
|
| Muscle Stretching Exercises | 2 | 2011 | 2 | 0.170 |
Why?
|
| Body Mass Index | 4 | 2015 | 925 | 0.170 |
Why?
|
| Occult Blood | 2 | 2019 | 161 | 0.160 |
Why?
|
| Postal Service | 2 | 2019 | 72 | 0.160 |
Why?
|
| Follow-Up Studies | 5 | 2017 | 1058 | 0.160 |
Why?
|
| Colonoscopy | 2 | 2019 | 261 | 0.160 |
Why?
|
| Patient Safety | 1 | 2020 | 37 | 0.160 |
Why?
|
| Reference Standards | 1 | 2019 | 14 | 0.150 |
Why?
|
| Self Care | 2 | 2011 | 139 | 0.150 |
Why?
|
| Causality | 1 | 2019 | 32 | 0.150 |
Why?
|
| Time Factors | 6 | 2020 | 989 | 0.150 |
Why?
|
| Disability Evaluation | 6 | 2017 | 38 | 0.150 |
Why?
|
| Adolescent | 10 | 2022 | 3464 | 0.150 |
Why?
|
| Professional Competence | 4 | 2012 | 15 | 0.150 |
Why?
|
| Physicians | 2 | 2011 | 114 | 0.150 |
Why?
|
| Heart Arrest | 2 | 2009 | 27 | 0.140 |
Why?
|
| Risk Factors | 7 | 2019 | 3108 | 0.140 |
Why?
|
| Age Factors | 5 | 2012 | 814 | 0.140 |
Why?
|
| Emergency Medical Services | 2 | 2009 | 41 | 0.140 |
Why?
|
| Allergens | 2 | 2009 | 7 | 0.140 |
Why?
|
| Motivation | 1 | 2019 | 103 | 0.140 |
Why?
|
| Confounding Factors (Epidemiology) | 2 | 2016 | 77 | 0.140 |
Why?
|
| Environmental Exposure | 2 | 2009 | 120 | 0.130 |
Why?
|
| Delivery of Health Care | 2 | 2019 | 374 | 0.130 |
Why?
|
| Observational Studies as Topic | 2 | 2014 | 44 | 0.130 |
Why?
|
| Hotlines | 1 | 2017 | 10 | 0.130 |
Why?
|
| Patient Compliance | 2 | 2017 | 262 | 0.130 |
Why?
|
| Fruit | 2 | 2014 | 79 | 0.130 |
Why?
|
| Oral Health | 1 | 2017 | 17 | 0.130 |
Why?
|
| Attitude to Health | 2 | 2019 | 142 | 0.130 |
Why?
|
| Vegetables | 2 | 2014 | 88 | 0.130 |
Why?
|
| Smoking Prevention | 1 | 2017 | 32 | 0.130 |
Why?
|
| Catastrophization | 1 | 2016 | 4 | 0.120 |
Why?
|
| Capacity Building | 1 | 2016 | 9 | 0.120 |
Why?
|
| Physical Therapists | 1 | 2016 | 2 | 0.120 |
Why?
|
| Reminder Systems | 1 | 2017 | 76 | 0.120 |
Why?
|
| Radiologists | 1 | 2016 | 6 | 0.120 |
Why?
|
| Self Efficacy | 1 | 2016 | 68 | 0.120 |
Why?
|
| Education, Medical | 1 | 2016 | 23 | 0.120 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2016 | 23 | 0.120 |
Why?
|
| Anxiety Disorders | 2 | 2022 | 96 | 0.120 |
Why?
|
| Chronic Disease | 4 | 2011 | 382 | 0.120 |
Why?
|
| Hemorrhage | 1 | 2016 | 62 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 57 | 0.110 |
Why?
|
| Epidemiologic Research Design | 2 | 2013 | 18 | 0.110 |
Why?
|
| Asthma | 2 | 2009 | 375 | 0.110 |
Why?
|
| Registries | 3 | 2012 | 449 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 311 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 4 | 2023 | 229 | 0.110 |
Why?
|
| Sex Factors | 3 | 2012 | 560 | 0.110 |
Why?
|
| Spatial Analysis | 1 | 2014 | 11 | 0.110 |
Why?
|
| Poisson Distribution | 2 | 2013 | 84 | 0.110 |
Why?
|
| Mind-Body Therapies | 1 | 2014 | 8 | 0.110 |
Why?
|
| Back Pain | 1 | 2014 | 32 | 0.100 |
Why?
|
| Educational Status | 2 | 2013 | 163 | 0.100 |
Why?
|
| Social Class | 2 | 2013 | 106 | 0.100 |
Why?
|
| Environment Design | 1 | 2014 | 65 | 0.100 |
Why?
|
| Relaxation Therapy | 2 | 2011 | 4 | 0.100 |
Why?
|
| Logistic Models | 3 | 2012 | 796 | 0.100 |
Why?
|
| Food Supply | 1 | 2014 | 41 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2014 | 278 | 0.100 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 58 | 0.100 |
Why?
|
| Meta-Analysis as Topic | 1 | 2013 | 23 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2014 | 98 | 0.100 |
Why?
|
| Risk | 2 | 2013 | 453 | 0.100 |
Why?
|
| Attitude of Health Personnel | 2 | 2011 | 197 | 0.100 |
Why?
|
| Electronic Mail | 2 | 2011 | 52 | 0.100 |
Why?
|
| Haemophilus Vaccines | 1 | 2013 | 19 | 0.090 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 2013 | 21 | 0.090 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2013 | 24 | 0.090 |
Why?
|
| Poverty | 1 | 2014 | 167 | 0.090 |
Why?
|
| Health Personnel | 1 | 2014 | 132 | 0.090 |
Why?
|
| Health Status | 2 | 2011 | 256 | 0.090 |
Why?
|
| Cholesterol | 1 | 2012 | 75 | 0.090 |
Why?
|
| Informed Consent | 2 | 2009 | 18 | 0.090 |
Why?
|
| Equipment Safety | 1 | 2011 | 2 | 0.090 |
Why?
|
| Quality of Life | 2 | 2023 | 477 | 0.090 |
Why?
|
| United States Food and Drug Administration | 1 | 2012 | 33 | 0.090 |
Why?
|
| Books | 1 | 2011 | 1 | 0.090 |
Why?
|
| Medical History Taking | 1 | 2011 | 30 | 0.090 |
Why?
|
| Goals | 1 | 2011 | 27 | 0.090 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2009 | 10 | 0.090 |
Why?
|
| Travel | 1 | 2011 | 10 | 0.080 |
Why?
|
| Patient Satisfaction | 2 | 2014 | 186 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2010 | 290 | 0.080 |
Why?
|
| Physician-Patient Relations | 2 | 2009 | 169 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2012 | 210 | 0.080 |
Why?
|
| Commission on Professional and Hospital Activities | 1 | 2010 | 1 | 0.080 |
Why?
|
| Risk Assessment | 4 | 2020 | 1047 | 0.080 |
Why?
|
| Office Visits | 1 | 2011 | 78 | 0.080 |
Why?
|
| Methods | 1 | 2010 | 4 | 0.080 |
Why?
|
| Consumer Behavior | 1 | 2010 | 27 | 0.080 |
Why?
|
| Linear Models | 1 | 2011 | 187 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 1887 | 0.080 |
Why?
|
| Hyperthermia, Induced | 1 | 2010 | 2 | 0.080 |
Why?
|
| Urban Health | 1 | 2010 | 35 | 0.080 |
Why?
|
| Breast | 1 | 2010 | 66 | 0.080 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2010 | 91 | 0.080 |
Why?
|
| Respiratory Sounds | 1 | 2009 | 10 | 0.080 |
Why?
|
| Boston | 1 | 2009 | 31 | 0.080 |
Why?
|
| Truth Disclosure | 1 | 2009 | 13 | 0.080 |
Why?
|
| Family Health | 1 | 2009 | 40 | 0.070 |
Why?
|
| Health Resources | 1 | 2009 | 35 | 0.070 |
Why?
|
| Verbal Behavior | 1 | 2009 | 2 | 0.070 |
Why?
|
| Sample Size | 2 | 2022 | 27 | 0.070 |
Why?
|
| Postmenopause | 1 | 2010 | 243 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2009 | 207 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2013 | 1430 | 0.070 |
Why?
|
| Emergency Medicine | 1 | 2008 | 5 | 0.070 |
Why?
|
| Remote Consultation | 1 | 2008 | 9 | 0.070 |
Why?
|
| Community Participation | 1 | 2008 | 29 | 0.070 |
Why?
|
| African Americans | 1 | 2011 | 394 | 0.070 |
Why?
|
| Telephone | 3 | 2017 | 157 | 0.070 |
Why?
|
| Idaho | 2 | 2019 | 24 | 0.070 |
Why?
|
| Patient Care | 1 | 2008 | 31 | 0.070 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 2 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 21 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 114 | 0.070 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2007 | 1 | 0.070 |
Why?
|
| Shock, Traumatic | 1 | 2007 | 1 | 0.070 |
Why?
|
| Dextrans | 1 | 2007 | 2 | 0.070 |
Why?
|
| Sodium Chloride | 1 | 2007 | 3 | 0.070 |
Why?
|
| Brain Injuries | 1 | 2007 | 14 | 0.070 |
Why?
|
| Oregon | 2 | 2019 | 168 | 0.070 |
Why?
|
| Massachusetts | 1 | 2007 | 58 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2007 | 68 | 0.060 |
Why?
|
| Observer Variation | 3 | 2011 | 34 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2008 | 147 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 67 | 0.060 |
Why?
|
| Infant, Newborn | 1 | 2009 | 828 | 0.060 |
Why?
|
| Weight Loss | 2 | 2022 | 302 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2007 | 657 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 1233 | 0.050 |
Why?
|
| Child | 2 | 2010 | 2433 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 291 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2022 | 2463 | 0.050 |
Why?
|
| Censuses | 2 | 2015 | 30 | 0.050 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 2 | 2014 | 97 | 0.050 |
Why?
|
| Vaccines, Attenuated | 1 | 2023 | 44 | 0.050 |
Why?
|
| Herpesvirus 3, Human | 1 | 2023 | 40 | 0.050 |
Why?
|
| Pain Management | 1 | 2022 | 56 | 0.050 |
Why?
|
| Recurrence | 1 | 2022 | 149 | 0.050 |
Why?
|
| Complementary Therapies | 2 | 2014 | 39 | 0.040 |
Why?
|
| Glycated Hemoglobin A | 1 | 2022 | 176 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2011 | 103 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2012 | 294 | 0.040 |
Why?
|
| Vaccines | 2 | 2014 | 225 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2013 | 569 | 0.040 |
Why?
|
| Quality Control | 1 | 2019 | 37 | 0.040 |
Why?
|
| Financial Support | 1 | 2019 | 6 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2019 | 50 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 289 | 0.040 |
Why?
|
| Demography | 1 | 2019 | 89 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 48 | 0.040 |
Why?
|
| Prevalence | 2 | 2011 | 785 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 410 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 185 | 0.030 |
Why?
|
| Pharmacists | 2 | 2008 | 53 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2019 | 249 | 0.030 |
Why?
|
| Dental Care | 1 | 2017 | 15 | 0.030 |
Why?
|
| Mobility Limitation | 1 | 2017 | 15 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 213 | 0.030 |
Why?
|
| United Kingdom | 1 | 2016 | 24 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 3 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 19 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2016 | 73 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 33 | 0.030 |
Why?
|
| Smoking Cessation | 1 | 2017 | 140 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 568 | 0.030 |
Why?
|
| Safety | 1 | 2014 | 43 | 0.030 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2014 | 11 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2014 | 15 | 0.030 |
Why?
|
| Hypolipidemic Agents | 1 | 2014 | 38 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2014 | 44 | 0.030 |
Why?
|
| Food Quality | 1 | 2013 | 3 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 197 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2013 | 56 | 0.020 |
Why?
|
| Energy Intake | 1 | 2013 | 98 | 0.020 |
Why?
|
| Commerce | 1 | 2013 | 37 | 0.020 |
Why?
|
| Health Education | 1 | 2013 | 79 | 0.020 |
Why?
|
| Vaccines, Conjugate | 1 | 2013 | 59 | 0.020 |
Why?
|
| Models, Educational | 1 | 2012 | 7 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2012 | 22 | 0.020 |
Why?
|
| Benchmarking | 1 | 2012 | 32 | 0.020 |
Why?
|
| Unnecessary Procedures | 1 | 2012 | 21 | 0.020 |
Why?
|
| Device Approval | 1 | 2011 | 2 | 0.020 |
Why?
|
| Clinical Trials, Phase IV as Topic | 1 | 2011 | 3 | 0.020 |
Why?
|
| Data Mining | 1 | 2011 | 18 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2011 | 57 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 2013 | 275 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 325 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 346 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 108 | 0.020 |
Why?
|
| Progestins | 1 | 2010 | 24 | 0.020 |
Why?
|
| Ownership | 1 | 2010 | 13 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 25 | 0.020 |
Why?
|
| Estrogens | 1 | 2010 | 55 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 322 | 0.020 |
Why?
|
| Ventricular Fibrillation | 1 | 2009 | 3 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2009 | 4 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 68 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2011 | 192 | 0.020 |
Why?
|
| Malpractice | 1 | 2009 | 11 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2010 | 102 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 191 | 0.020 |
Why?
|
| Resuscitation | 1 | 2008 | 2 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2010 | 167 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2008 | 35 | 0.020 |
Why?
|
| Community-Institutional Relations | 1 | 2008 | 42 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 8 | 0.020 |
Why?
|
| Communication | 1 | 2009 | 183 | 0.020 |
Why?
|
| Disease Management | 1 | 2008 | 106 | 0.020 |
Why?
|
| Process Assessment (Health Care) | 1 | 2007 | 22 | 0.020 |
Why?
|
| Ethnic Groups | 1 | 2010 | 418 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2008 | 288 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2007 | 97 | 0.020 |
Why?
|